StonvexLoading…
StonvexStonvexStonvexCore line items from DOCU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $3.22B | $2.98B | $2.76B | $2.52B |
Operating Income | $298.58M | $199.93M | $31.63M | $-88.03M |
Net Income | $309.08M | $1.07B | $73.98M | $-97.45M |
EPS (Diluted) | $1.48 | $5.08 | $0.36 | $-0.49 |
Total Assets | $4.23B | $4.01B | $2.97B | $3.01B |
Total Liabilities | $2.31B | $2.01B | $1.84B | $2.40B |
Cash & Equivalents | $602.44M | $648.62M | $797.06M | $721.89M |
Free Cash Flow OCF − CapEx | $1.06B | $920.28M | $887.13M | $429.11M |
Shares Outstanding | 197.76M | 202.48M | 205.33M | 201.90M |